OM:ELOS B

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Elos Medtech AB (publ) develops and manufactures medical devices and components for the medical technology industry. More Details


Snowflake Analysis

Undervalued with reasonable growth potential.

Share Price & News

How has Elos Medtech's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ELOS B is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: ELOS B's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

-1.0%

ELOS B

3.4%

SE Medical Equipment

0.7%

SE Market


1 Year Return

-4.6%

ELOS B

16.3%

SE Medical Equipment

17.7%

SE Market

Return vs Industry: ELOS B underperformed the Swedish Medical Equipment industry which returned 17.5% over the past year.

Return vs Market: ELOS B underperformed the Swedish Market which returned 19.6% over the past year.


Shareholder returns

ELOS BIndustryMarket
7 Day-1.0%3.4%0.7%
30 Day17.9%10.4%9.5%
90 Day8.6%3.6%9.3%
1 Year-4.6%-4.6%17.9%16.3%19.6%17.7%
3 Year73.3%55.8%79.1%58.8%43.3%27.7%
5 Year-2.7%-14.6%70.2%41.9%69.2%36.5%

Long-Term Price Volatility Vs. Market

How volatile is Elos Medtech's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Elos Medtech undervalued compared to its fair value and its price relative to the market?

44.1%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: ELOS B (SEK104) is trading below our estimate of fair value (SEK185.88)

Significantly Below Fair Value: ELOS B is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: ELOS B is good value based on its PE Ratio (25.8x) compared to the SE Medical Equipment industry average (32.3x).

PE vs Market: ELOS B is poor value based on its PE Ratio (25.8x) compared to the Swedish market (22.6x).


Price to Earnings Growth Ratio

PEG Ratio: ELOS B is good value based on its PEG Ratio (0.8x)


Price to Book Ratio

PB vs Industry: ELOS B is good value based on its PB Ratio (1.5x) compared to the SE Medical Equipment industry average (4.3x).


Next Steps

Future Growth

How is Elos Medtech forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

31.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ELOS B's forecast earnings growth (31.2% per year) is above the savings rate (0.5%).

Earnings vs Market: ELOS B's earnings (31.2% per year) are forecast to grow faster than the Swedish market (11.5% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ELOS B's revenue (16.8% per year) is forecast to grow faster than the Swedish market (3.4% per year).

High Growth Revenue: ELOS B's revenue (16.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ELOS B's Return on Equity is forecast to be low in 3 years time (10.1%).


Next Steps

Past Performance

How has Elos Medtech performed over the past 5 years?

12.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ELOS B has a large one-off gain of SEK44.8M impacting its September 30 2020 financial results.

Growing Profit Margin: ELOS B's current net profit margins (5.6%) are higher than last year (5%).


Past Earnings Growth Analysis

Earnings Trend: ELOS B's earnings have grown by 12.1% per year over the past 5 years.

Accelerating Growth: ELOS B's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ELOS B had negative earnings growth (-7.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (49.3%).


Return on Equity

High ROE: ELOS B's Return on Equity (5.8%) is considered low.


Next Steps

Financial Health

How is Elos Medtech's financial position?


Financial Position Analysis

Short Term Liabilities: ELOS B's short term assets (SEK341.5M) exceed its short term liabilities (SEK172.4M).

Long Term Liabilities: ELOS B's short term assets (SEK341.5M) exceed its long term liabilities (SEK314.7M).


Debt to Equity History and Analysis

Debt Level: ELOS B's debt to equity ratio (43.7%) is considered high.

Reducing Debt: ELOS B had negative shareholder equity 5 years ago, but is now positive and has therefore improved.

Debt Coverage: ELOS B's debt is well covered by operating cash flow (47.6%).

Interest Coverage: ELOS B's interest payments on its debt are not well covered by EBIT (0.8x coverage).


Balance Sheet


Next Steps

Dividend

What is Elos Medtech current dividend yield, its reliability and sustainability?

1.22%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ELOS B's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ELOS B's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ELOS B's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ELOS B's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: ELOS B is not paying a notable dividend for the Swedish market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ELOS B's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.4yrs

Average management tenure


CEO

Jan Wahlström (53 yo)

4.42yrs

Tenure

Mr. Jan Wahlström has been the Chief Executive Officer and President of Elos Medtech AB since July 1, 2016. Mr. Wahlström joined Elos Medtech from his role as President of Larodan AB. Mr. Wahlström served ...


Leadership Team

NamePositionTenureCompensationOwnership
Jan Wahlström
President & CEO4.42yrsno data0.15%
SEK 1.3m
Ewa Linsäter
Chief Financial Officer1.5yrsno data0.051%
SEK 435.1k
Malin Gustavsson
Marketing Directorno datano data0.0059%
SEK 49.6k
Anders Björklund
QA/RA Quality Directorno datano data0.0012%
SEK 10.5k
Sören Larsson
President of Forshemgruppen AB17.92yrsno datano data
Søren Olesen
CEO of Elos Medtech Pinol A/S & Business Unit Director of Dentalno datano data2.98%
SEK 25.3m
Mathias Andersson
Chief Executive Officer of Elos Medtech Microplast ABno datano datano data
Jodie Gilmore
CEO of Elos Medtech Onyx & Global Business Director of Orthopedicsno datano datano data
Conny Jakobsson
Chief Executive Officer of Elos Medtech Tianjin Co. Ltdno datano datano data
Sam Svännel
Chief Executive Officer of Elos Medtech Timmersdala ABno datano datano data

4.4yrs

Average Tenure

50.5yo

Average Age

Experienced Management: ELOS B's management team is considered experienced (4.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yvonne Mårtensson
Independent Chairman of the Board3.92yrskr400.00k0.29%
SEK 2.4m
Jon Risfelt
Independent Director3.67yrskr235.00k0.036%
SEK 307.7k
Jeppe Magnusson
Independent Director8.92yrskr175.00k0.049%
SEK 414.3k
Anders Birgersson
Independent Director4.67yrskr175.00k0.012%
SEK 99.2k
Claes Hansson
Independent Director1.92yrskr215.00k0.011%
SEK 94.5k
Hanna Wilkman
Independent Director1.92yrskr175.00kno data

3.8yrs

Average Tenure

62.5yo

Average Age

Experienced Board: ELOS B's board of directors are considered experienced (3.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Elos Medtech AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Elos Medtech AB (publ)
  • Ticker: ELOS B
  • Exchange: OM
  • Founded: 1923
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr847.140m
  • Shares outstanding: 8.07m
  • Website: https://www.elosmedtech.com

Number of Employees


Location

  • Elos Medtech AB (publ)
  • Torsgatan 5B
  • Gothenburg
  • Västra Götaland County
  • 411 04
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ELOS BOM (OMX Nordic Exchange Stockholm)YesSeries B SharesSESEKMay 1993
0IZXLSE (London Stock Exchange)YesSeries B SharesGBSEKMay 1993
ELOSBSBATS-CHIXE (BATS 'Chi-X Europe')YesSeries B SharesGBSEKMay 1993
EI9DB (Deutsche Boerse AG)YesSeries B SharesDEEURMay 1993

Biography

Elos Medtech AB (publ) develops and manufactures medical devices and components for the medical technology industry. The company operates in three segments: Dental, Orthopedics, and Life Science. Its produ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/12/02 19:36
End of Day Share Price2020/12/02 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.